Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Allergy
|
August 24, 2013
Utilizing metabolomics to distinguish asthma phenotypes: strategies and clinical implications
N Reisdorph, M E Wechsler
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Anti-interleukin therapy in asthma
R M Dunn, M E Wechsler
Journal of the American College of Cardiology
|
April 1, 1990
Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias
E G Giardina, M E Wechsler
Chest
|
July 29, 1999
Zafirlukast and Churg-Strauss syndrome
M E Wechsler, J M Drazen
The Lancet. Respiratory Medicine
|
April 20, 2015
Corrections. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
M Castro, J Zangrilli, M E Wechsler
Drug Safety
|
October 8, 1999
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
M E Wechsler, R Pauwels, J M Drazen
Allergy
|
July 20, 2017
Asthma in the elderly and late-onset adult asthma
R M Dunn, P J Busse, M E Wechsler
Journal of the American College of Cardiology
|
June 1, 1991
Time course of moricizine's effect on signal-averaged and 12 lead electrocardiograms: insights into mechanism of action
M E Wechsler, J S Steinberg, E G Giardina
Journal of Clinical Pharmacology
|
July 1, 1994
Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients
E G Giardina, M E Wechsler, M Dolgopiatova, et al.
Mayo Clinic Proceedings
|
June 14, 2000
Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents
P F Dellaripa, M E Wechsler, M E Roth, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Allergy
|
August 24, 2013
Utilizing metabolomics to distinguish asthma phenotypes: strategies and clinical implications
N Reisdorph, M E Wechsler
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Anti-interleukin therapy in asthma
R M Dunn, M E Wechsler
Journal of the American College of Cardiology
|
April 1, 1990
Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias
E G Giardina, M E Wechsler
Chest
|
July 29, 1999
Zafirlukast and Churg-Strauss syndrome
M E Wechsler, J M Drazen
The Lancet. Respiratory Medicine
|
April 20, 2015
Corrections. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
M Castro, J Zangrilli, M E Wechsler
Drug Safety
|
October 8, 1999
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
M E Wechsler, R Pauwels, J M Drazen
Allergy
|
July 20, 2017
Asthma in the elderly and late-onset adult asthma
R M Dunn, P J Busse, M E Wechsler
Journal of the American College of Cardiology
|
June 1, 1991
Time course of moricizine's effect on signal-averaged and 12 lead electrocardiograms: insights into mechanism of action
M E Wechsler, J S Steinberg, E G Giardina
Journal of Clinical Pharmacology
|
July 1, 1994
Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients
E G Giardina, M E Wechsler, M Dolgopiatova, et al.
Mayo Clinic Proceedings
|
June 14, 2000
Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents
P F Dellaripa, M E Wechsler, M E Roth, et al.
Page
of 3